Aim / Mission
The main objectives of the EORTC Endocrine Tumor Task Force (EnTF) are to:
- run potentially practice changing clinical trials;
- define and implement a global translational research strategy to better identify new targets and predictive and prognostic factors which could identify sub-populations likely to benefit;
- ensure that material and resources are used as efficiently as possible in order to answer key questions and better serve patient needs.
The EnTF benefits from interactions with other EORTC groups and the support of EORTC structures such as the Translational Research Advisory Committee, the New Drug Advisory Committee, the Imaging Platform, and EORTC Headquarters expertise (e.g. the Quality of Life Department, Early Project Optimization Department, Regulatory Affairs, Pharmacovigilance, biostatistics, and methodology). To achieve these objectives, the EnTF will create subcommittees and other administrative structures as needed.